Skip to main content
SpringerLink
Log in

Phenobarbital Removal Characteristics of Three Brands of Activated Charcoals: A System Analysis Approach

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The in vivo phenobarbital removal characteristics of three brands of activated charcoal (Actidose, Charcoaid, Superchar) were studied in normal volunteers using a system analysis approach. The subjects received a 200-mg dose of oral or intravenous phenobarbital followed by a single oral dose of 30 g of one of the three charcoals in a randomized crossover design. The relative merits of the three charcoals in enhancing the removal of oral and intravenous phenobarbital were assessed using a system analysis approach. The removal clearance, time to peak (t p), peak removal clearance (R max), percentage of dose removed (PCT∞), and phenobarbital removal clearance (CLr) were calculated for the oral and intravenous treatments. Superchar had a pulse-like effect, with the shortest t p and the largest R max. Actidose and Charcoaid had similar effects, with Actidose inducing slightly greater phenobarbital removal. Superchar has the highest surface area and relative percentage of surface hydroxyl groups, whereas Actidose has the lowest surface area and relative percentage of surface hydroxyl groups of the three charcoals studied. Although correlations between the in vitro and the in vivo phenobarbital adsorption characteristics of the three charcoals may be difficult due to the presence of preservatives and palatibility enhancers in the commercial preparations, it appears that the in vivo effectiveness decreases as the surface area and the concentration of surface hydroxyl groups decrease. The proposed system analysis approach requires fewer assumptions than methods based on compartmental or physiologic approaches and has the advantage of describing the phenobarbital removal in a dynamic manner.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. T. Litovitz and J. C. Veltri. 1984 annual report of the American Association of Poison Control Centers National Data Collection System. Am. J. Emerg. Med. 3:423–450 (1985).

    Google Scholar 

  2. J. G. Setter, J. F. Maher, and G. E. Schreiner. Barbiturate intoxication: Evaluation of therapy including dialysis in a large series selectively referred because of severity. Arch. Intern. Med. 117:224–236 (1966).

    Google Scholar 

  3. J. B. Costello and A. Poklis. Treatment of massive phenobarbital overdose with dopamine diuresis. Arch. Intern. Med. 141:938–940 (1981).

    Google Scholar 

  4. R. H. Mychetzky and N. A. Lassen, Forced diuresis in treatment of acute barbiturate poisoning. In H. Matthew (ed.), Acute Barbiturate Poisoning, Excerpta Medica, Amsterdam, 1971, pp. 195–204.

    Google Scholar 

  5. M. J. Berg, W. G. Berlinger, M. J. Goldberg, R. Spector, and G. F. Johnson. Acceleration of the body clearance of phenobarbital by activated charcoal. N. Engl. J. Med. 307:642–644 (1982).

    Google Scholar 

  6. M. J. Berg, J. Q. Rose, D. E. Wurster, S. Rahman, R. W. Fincham, and D. D. Scheottelius. Effect of charcoal and sorbitol-charcoal suspension on the elimination of intravenous phenobarbital. Ther. Drug Monit. 9:41–47 (1987).

    Google Scholar 

  7. D. A. R. Boldy, J. A. Vale, and L. F. Prescott. Treatment of phenobarbitone poisoning with repeated oral administration of activasted charcoal. Q. J. Med. 235:997–1002 (1986).

    Google Scholar 

  8. P. J. Neuvonen and E. Elonen. Effect of activated charcoal on absorption and elimination of phenobabitone, carbamezapine and phenylbutazone in man. Eur. J. Pharmacol. 17:51–57 (1980).

    Google Scholar 

  9. H. Yatzidis. The use of ion exchange resins and charcoal in acute barbiturate poisoning. In H. Matthew (ed.), Acute Barbiturate Poisoning, Excerpta Medica, Amsterdam, 1971, pp. 195–204.

    Google Scholar 

  10. E. P. Krenzelok and M. B. Heller. Effectiveness of commercially available aqueous activated charcoal products. Ann. Emerg. Med. 16:1340–1343 (1987).

    Google Scholar 

  11. E. P. Krenzelok and R. M. Lush. Container residue after the administration of aqueous activated charcoal products. Am J. Emerg. Med. 9:144–146 (1991).

    Google Scholar 

  12. C. D. Curd-Sneed, L. E. McNattle, and J. L. Stewart. Absorption of sodium pentobarbital by three types of activated charcoal. Vet. Hum. Toxicol. 28:524–526 (1986).

    Google Scholar 

  13. A. L. Piccioni, L. Chin, and H. E. Liard. Activated charcoal preparations: Relative antidotal efficacy. Clin. Toxicol. 28:524–526 (1974).

    Google Scholar 

  14. W. R. Gillespie, P. Veng-Pedersen, M. J. Berg, and D. D. Schottelius. Linear systems approach to the analysis of an induced drug removal process. Phenobarbital removal by oral activated charcoal. J. Pharmacokin. Biopharm. 14:19–28 (1986).

    Google Scholar 

  15. W. E. Gillespie, P. Veng-Pedersen, and T. P. Gibson. Deconvolution applied to the kinetics of extracorporeal drug removal. Haemodialysis of cefsulodin. Eur. J. Clin. Pharmacol. 29:503–509 (1985).

    Google Scholar 

  16. D. D. Schottelius. Homogeneous immunoassay system (EMIT) for quantitation of antiepileptic drugs in biological fluids. In C. E. Pippenger, J. K. Perry, and H. Kutt (eds.), Antiepileptic Drugs: Quantitative Analysis and Interpretation, Raven Press, New York, 1978, pp. 95–108.

    Google Scholar 

  17. D. J. Cutler, Linear system analysis in pharmacokinetics. J. Pharmacokin. Biopharm. 6:265–282 (1978).

    Google Scholar 

  18. P. Veng-Pedersen. Curve fitting and modeling in pharmacokinetics and some practical experience with NONLIN and a new program FUNFIT. J. Pharmacokin. Biopharm. 5:513–531 (1977).

    Google Scholar 

  19. J. Alvin. The effect of liver disease in man on the disposition of phenobarbital. J. Pharmacol. Exp. Ther. 192:224–235 (1975).

    Google Scholar 

  20. G. Levy. Gastrointestinal clearance of drugs with activated charcoal. N. Engl. J. Med. 307:676–678 (1982).

    Google Scholar 

  21. K. Arimori, Y. Hashimoto, and M. Nakano. Comparison of intestinal and peritoneal dialysis of theophylline and phenobarbitone in rats. J. Pharm. Pharmacol. 42:726–728 (1990).

    Google Scholar 

  22. G. M. Burke, D. E. Wurster, M. J. Berg, P. Veng-Pedersen, and D. D. Schottelius. Surface characterization of activated charcoal by x-ray photoelectron spectroscopy (XPS): Correlation with phenobarbital adsorption data. Pharm. Res. 9:126–130 (1992).

    Google Scholar 

  23. G. M. Burke, D. E. Wurster, V. Buraphacheep, M. J. Berg, P. Veng-Pedersen, and D. D. Schottelius. Model selection for the adsorption of phenobarbital by activated charcoal. Pharm. Res. 8:228–231 (1991).

    Google Scholar 

  24. D. E. Wurster, G. M. Burke, M. J. Berg, P. Veng-Pedersen, and D. D. Schottelius. Phenobarbital adsorption from simulated intestinal fluid, U.S.P., and simulated gastric fluid, U.S.P., by two activated charcoals. Pharm. Res. 5:183–186 (1988).

    Google Scholar 

  25. T. F. Eisen, P. A. Grbcich, P. G. Lacouture, M. W. Shannon, and A. Woolf. The adsorption of salicylates by a milk chocolate-charcoal mixture. Ann. Emerg. Med. 20:143–146 (1991).

    Google Scholar 

  26. L. Chin, A. Picchioni, W. M. Bourn, and H. E. Laird. Optimal antidotal dose of activated charcoal. Toxicol. Appl. Pharmacol. 26:103–108 (1973).

    Google Scholar 

  27. N. Barzaghi, G. Gatti, R. Manni, C. A. Galimberti, C. Zucca, E. Perucca, and A. Tartara. Comparative pharmacokinetics and pharmacodynamics of eterobarbital and phenobarbital in normal volunteers. Eur. J. Drug Metab. Pharmacokin. 16:81–87 (1991).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, The University of Iowa, Iowa City, Iowa, 52242

    Nishit B. Modi, Peter Veng-Pedersen, Dale Eric Wurster & Mary J. Berg

Authors
  1. Nishit B. Modi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Veng-Pedersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dale Eric Wurster
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mary J. Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dorothy D. Schottelius
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Modi, N.B., Veng-Pedersen, P., Wurster, D.E. et al. Phenobarbital Removal Characteristics of Three Brands of Activated Charcoals: A System Analysis Approach. Pharm Res 11, 318–323 (1994). https://doi.org/10.1023/A:1018980029882

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018980029882

Search

Navigation